Implication of circulating memory B cells in late‐onset myasthenia gravis

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-1961|6|3|220-221

ISSN： 1759-1961

Source： CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol.6, Iss.3, 2015-08, pp. : 220-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating memory B cells are reduced in patients with late‐onset myasthenia gravis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 3, 2015-08 ,pp. : 322-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Japanese clinical guidelines for myasthenia gravis: Putting into practice

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 21-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life measures for myasthenia gravis and evaluation of non‐motor symptoms

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 32-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

How should we use calcineurin inhibitors in myasthenia gravis?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 118-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of myasthenia gravis patients with calcineurin inhibitors in Japan: A retrospective analysis of outcomes

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 195-200

John Wiley & Sons Inc

Access to resources Recommend Favorite